Recent Trends in Oncology

Clinical trials show that modified FOLFOX chemotherapy plus active symptom control improve OS with active symptom control alone among patients with locally advanced or metastatic biliary tract cancer for people treated with cisplatin plus gemcitabine. Explore more oncology at: http://bit.ly/2K4sRl4

#CancerConferences  #CancerSummit2019